Summary
In PGF2α-precontracted pulmonary arteries with intact endothelium, 5-hydroxytryptamine (5-HT, 1.0-100 nmol/l) caused a concentration-dependent reversible relaxation, at higher concentrations the contractile response prevailed. In endothelium-denuded vessels relaxation was absent. 5-HT-induced relaxation of precontracted pulmonary arteries was probably mediated by release of an endothelium-derived relaxing factor (EDRF). Preincubation of the arteries with methylene blue or NG-nitro-Lrarginine (200 μmol/l) attenuated the relaxant effect. The 5-HT-induced relaxation was accompanied by an increase in cGMP. Indomethacin (3 μmol/l) did not influence the 5-HT-induced relaxation indicating that eicosanoids are not involved in the relaxant response to 5-HT.
The 5-HT1C and 5-HT2 receptor agonist α-methyl-5HT was as potent as 5-HT in inducing relaxation. The rank order of relaxant potency of the agonists investigated was α-methyl-5-HT > 5-HT > 5-methoxytryptamine > tryptamine > ω-methyl-5-HT > 5-carboxamidotryptamine >2-methyl-5-HT > 5,6-dihydroxytryptamine > m-chlorophenylpiperazine >sumatriptan > 8-OH-DPAT.
Phentolamine, pindolol and ICS 205-930 did not interfere with the relaxant effect. The 5-HT2 receptor antagonist ketanserin (1 μmol/l) inhibited the contractile response but did not alter vasodilatation. Apart from the blockade of the contractile effects, mesulergine, cyproheptadine and mianserin (0.1-3.0 μmol/l, each) induced a parallel shift to the right of the concentration-response curve for the relaxation induced by a-methyl-5-HT or 5-HT. Spiperone (0.3 μmol/l) exerted weak inhibitory effects on relaxation and contraction. The most potent (noncompetitive) antagonist against relaxant responses was metitepine (0.1-1.0 μmol/l) which markedly depressed the relaxant maximum effect of the agonists.
The failure of ketanserin and ICS 205-930 to inhibit the relaxant effect of 5-HT receptor agonists suggests that classical 5-HT2 and 5-HT3 receptors are not involved in the endothelium-dependent relaxation. Comparison of the rank order of potencies of agonists and antagonists with their affinities for brain binding sites revealed that the endothelial 5-HT receptors are similar to the 5-HT1C receptor subtype. Furthermore, the endothelial receptors exhibit marked similarity to the recently cloned 5-HT receptor mediating contraction of the rat stomach fundus.
Similar content being viewed by others
References
Bax WA, Van Heuven-Nolsen D, Bos E, Simoons ML, Saxena PR (1992) 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn-Schmiedeberg's Arch Pharmacol 345:500–508
Bockaert J, Fozard JR, Dumuis A, Clarke DE (1992) The 5-HT4 receptor: a place in the sun. Trends Pharmacol Sci 13:141–145
Bodelsson M, Arneklo-Nobin B, Törnebrandt K (1992) Endothelium-dependent relaxation to serotonin mediated via 5-HT1C receptors. J Vascular Res 29:87
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–630
Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Wells FC, Wallwork J (1990) Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J 3:633–638
Engel G, Gothert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of [3H] 5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. NaunynSchmiedeberg's Arch Pharmacol 324:116–124
Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. NaunynSchmiedeberg's Arch Pharmacol 332:1–7
Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, Stuhmer W, Lubbert H (1992) Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J 11:3481–3487
Fozard JR (1990) Agonists and antagonists of 5-HT3 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine. Kluwer Academic Publishers, Dordrecht London Boston, pp 101–115
Glusa E, Müller-Schweinitzer E (1990) Heterogeneity of 5-HT receptors in human veins. Blood Vessels 27:38
Glusa E, Richter M (1992) 5-HT1C-like receptors mediate endothelium-dependent relaxant response to 5-HT in porcine pulmonary arteries. Naunyn-Schmiedeberg's Arch Pharmacol [Suppl] 346:R1
Goldie RG, Paterson JW, Wale JL (1982) Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery. Br J Pharmacol 76:515–521
Greenberg B, Rhoden K, Barnes PJ (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol 252: H434-H438
Gruetter CA, Lemke SM (1986) Bradykinin-induced endothelium-dependent relaxation of bovine intrapulmonary artery and vein. Eur J Pharmacol 122:363–367
Gruetter CA, Ignarro LJ, Hyman AL, Kadowitz PJ (1981) Contractile effects of 5-hydroxytryptamine in isolated intrapulmonary arteries and veins. Can J Physiol Pharmacol 59:157–162
Hamel E, Bouchard D (1991) Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites. Br J Pharmacol 102:227–233
Hoyer D (1989) 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard JF (ed) The peripheral action of 5-hydroxytryptamine. Oxford University Press, Oxford New York Tokyo, pp 72–99
Kalkman HO, Fozard JR (1991) Further definition of the 5-HT receptor mediating contraction of rat stomach fundus: relation to 5-HT1D recognition sites. In: Fozard JR, Saxena PR (eds) Serotonin: molecular biology, receptors and functional effects. Birkhäuser, Basel, pp 153–160
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Martin GR, Leff P, Cambridge D, Barrett VJ (1987) Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. NaunynSchmiedeberg's Arch Pharmacol 336:365–373
McCormack D (1990) Endothelium-derived relaxing factors and the human pulmonary circulation. Lung [Suppl]:35–42
Molderings GJ, Engel G, Roth E, Gothert M (1989) Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 340:300–308
Molderings GJ, Werner K, Likungu J, Gothert M (1990) Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT1D subtype. Naunyn-Schmiedeberg's Arch Pharmacol 342: 371–377
Mylecharane EJ (1990) Mechanisms involved in serotonin-induced vasodilatation. Blood Vessels 27:116–126
Nowak G, Markwardt F (1980) Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Exp Pathol 18:428–443
Nowak G, Markwardt F (1985) Influence of cyproheptadine on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Thromb Haemost 53:252–254
Parsons AA (1991) 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12:310–315
Ruffolo Jr RR, Hieble JP, Brooks DP, Feuerstein GZ, Nichols AJ (1991) Drug receptors and control of the cardiovascular system: Recent advances. Prog Drug Res 36:117–360
Schoeffter P, Hoyer D (1989) Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT{1D receptors: do discriminatory 5-HT1B receptor ligands exist?} Naunyn-Schmiedeberg's Arch Pharmacol 339:675–683
Schoeffter P, Hoyer D (1990) 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J Pharmacol Exp Ther 252:387–395
Sumner MJ (1991) Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br J Pharmacol 102:938–942
Sumner MJ, Humphrey PPA (1989) 5-HT1D binding sites in porcine brain can be sub-divided by GR43175. Br J Pharmacol 98:29–31
Van Rossum JM (1963) Cumulative dose-response curves. 11. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharamcodyn 143: 299–330
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 337:595–601
Author information
Authors and Affiliations
Additional information
Correspondence to E. Glusa at the above address
Rights and permissions
About this article
Cite this article
Glusa, E., Richter, M. Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 347, 471–477 (1993). https://doi.org/10.1007/BF00166737
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166737